Fig. 7From: Targeted delivery of HSP90 inhibitors for efficient therapy of CD44-positive acute myeloid leukemia and solid tumor-colon cancer(A) In vivo experimental scheme of leukemia cells infiltrated. (B) Infiltration analysis of leukemia cells in peripheral blood (PB), bone marrow (BM) and spleen determined by flow cytometry (n = 3). *p < 0.05, **p < 0.01, ***p < 0.001. (C) Representative views of H&E-stained BM and spleen sections, scale bar 100 μmBack to article page